AUD3.00
0.00% today
Australia, Sep 15, 08:10 am CET
ISIN
AU000000SIG5
Symbol
SIG

Sigma Pharmaceuticals Stock price

AUD3.00
+0.17 6.07% 1M
+0.05 1.77% 6M
+0.39 14.98% YTD
+1.59 112.89% 1Y
+2.33 350.32% 3Y
+2.46 460.33% 5Y
+2.47 467.86% 10Y
+2.32 339.11% 20Y
Australia, Closing price Mon, Sep 15 2025
+0.00 0.00%
ISIN
AU000000SIG5
Symbol
SIG

Key metrics

Basic
Market capitalization
AUD34.5b
Enterprise Value
AUD36.4b
Net debt
AUD1.9b
Cash
AUD138.8m
Shares outstanding
11.5b
Valuation (TTM | estimate)
P/E
75.0 | 49.1
P/S
3.8 | 3.5
EV/Sales
4.0 | 3.7
EV/FCF
111.2
P/B
7.4
Dividends
DPS
AUD0.01
Yield 1Y | 5Y
0.2% | 1.1%
Growth 1Y | 5Y
-49.2% | -12.4%
Payout 1Y | 3Y
10.0% | 61.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
AUD9.0b | AUD9.9b
EBITDA
- | AUD1.1b
EBIT
AUD752.5m | AUD1.0b
Net Income
AUD512.4m | AUD702.1m
Free Cash Flow
AUD327.3m
Growth (TTM | estimate)
Revenue
- | 65.3%
EBITDA
- | 2,166.7%
EBIT
- | 40.6%
Net Income
- | 32.5%
Free Cash Flow
-
Margin (TTM | estimate)
Gross
18.2%
EBITDA
- | 10.8%
EBIT
8.3%
Net
5.7% | 7.1%
Free Cash Flow
3.6%
Financial Health
Equity Ratio
56.4%
Return on Equity
11.4%
ROCE
11.4%
ROIC
7.7%
Debt/Equity
0.4
More
EPS
AUD0.0
FCF per Share
AUD0.0
Short interest
-
Employees
2k
Rev per Employee
AUD3.2m
Show more

Is Sigma Pharmaceuticals a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Sigma Pharmaceuticals Stock Analysis

Unlock Scores for Free

Analyst Opinions

13 Analysts have issued a Sigma Pharmaceuticals forecast:

8x Buy
62%
4x Hold
31%
1x Sell
8%

Analyst Opinions

13 Analysts have issued a Sigma Pharmaceuticals forecast:

Buy
62%
Hold
31%
Sell
8%

Financial data from Sigma Pharmaceuticals

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
9,047 9,047
-
100%
- Direct Costs 7,401 7,401
-
82%
1,646 1,646
-
18%
- Selling and Administrative Expenses 890 890
-
10%
- Research and Development Expense - -
-
-
- -
-
-
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 752 752
-
8%
Net Profit 512 512
-
6%

In millions AUD.

Don't miss a Thing! We will send you all news about Sigma Pharmaceuticals directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sigma Healthcare Ltd. engages in the manufacture and distribution of pharmaceutical products through pharmacy, grocery channels, and private label. The firm operates through the Amcal, Guardian, PharmaSave, Chemist King, and Discount Drug Stores retail brands. It also involves in the provision of services to retail pharmacists in Australia. The company was founded on July 2, 1999 and is headquartered in Rowville, Australia.

Head office Australia
CEO Vikesh Ramsunder
Employees 1,900
Founded 1999
Website sigmahealthcare.com.au

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today